Influence of the asexual parasite biomass on in vitro susceptibility of Plasmodium falciparum to antimalarial drugs in Abidjan
Brice,B.K.; William,Y.; Lacinan,O.; Leonardo,B.; Joseph,D.A.
African Journal Of Biotechnology: 8, 936-940. Ef
2008
ISSN/ISBN: 1684-5315 Document Number: 200465
The in vitro activities of artemisinin, dihydroartemisinin (the biologically active metabolite of artemisinin derivatives), chloroquine and pyronaridine were assessed in 32 isolates of Plasmodium falciparum from Abobo in the northern of Abidjan district (Cote d'Ivoire) using a test based on the standard microtechnique recommended by the World Health Organization (WHO). The parasites densities were ranged between 8,000 and 540 000 rings/ micro l of blood.
Document emailed within 1 workday
Related Documents
Ross, A.; Killeen, G.; Smith, T. 2006: Relationships between host infectivity to mosquitoes and asexual parasite density in Plasmodium falciparum American Journal of Tropical Medicine and Hygiene 75(2 Suppl): 32-37Pradines, B.; Tall, A.; Rogier, C.; Spiegel, A.; Mosnier, J.; Marrama, L.; Fusai, T.; Millet, P.; Panconi, E.; Trape, J.F.; Parzy, D. 2002: In vitro activities of ferrochloroquine against 55 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs Tropical Medicine and International Health: Tm and Ih 7(3): 265-270
Al-Shamahy, H.; Al-Harazy, A.H.; Harmal, N.S.; Al-Kabsi, A.M. 2007: The prevalence and degree of resistance of Plasmodium falciparum to first-line antimalarial drugs: an in vitro study from a malaria endemic region in Yemen Annals of Saudi Medicine 27(6): 432-436
Ang, H.H.; Chan, K.L.; Mak, J.W. 1998: In vitro susceptibility studies of Malaysian Plasmodium falciparum isolates and clones against schizontocidal drugs Folia Parasitologica 45(3): 196-198
Andriantsoanirina, V.; Ménard, D.; Tuséo, L.; Ratsimbasoa, A.; Durand, R. 2011: Resistance of Plasmodium falciparum to antimalarial drugs: impact on malaria pre-elimination in Madagascar Medecine Tropicale: Revue du Corps de Sante Colonial 71(3): 298-304
Biswas, S. 2002: Enhancement of antimalarial activity of chloramphenicol against Indian Plasmodium falciparum isolates in vitro by chloroquine Indian Journal of Malariology 39(1-2): 26-33
Biswas, S. 2001: In-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant Plasmodium falciparum Journal of Postgraduate Medicine 47(4): 240-243
Coppel, R.L.; Crewther, P.E.; Favaloro, J.M.; Stahl, H.D. 1986: Cloning of asexual blood-stage antigens of Plasmodium falciparum Papua and New Guinea Medical Journal 29(1): 75-80
Anders, R.F.; Brown, G.V.; Coppel, R.L.; Stahl, H.D.; Bianco, A.E.; Favaloro, J.M.; Crewther, P.E.; Culvenor, J.G.; Kemp, D.J. 1985: Potential vaccine antigens of the asexual blood-stages of Plasmodium falciparum Developments in Biological Standardization 62: 81-89
Zhou, Y.C.; Guan, W.B.; Huang, W.J.; Pan, W.Q. 1983: Effect of chloroquine on different stages of asexual forms of Plasmodium falciparum in culture Zhongguo Yao Li Xue Bao 4(2): 137-140
Tinto, H.; Ouedraogo, J.B.; Traoré, B.; Coulibaly, S.O.; Guiguemde, T.R. 2001: In vitro susceptibility of 232 isolates of Plasmodium falciparum to antimalarials in Burkina Faso (West Africa) Bulletin de la Societe de Pathologie Exotique 94(2 Part 2): 188-191
Nsanzabana, C.; Rosenthal, P.J. 2011: In vitro activity of antiretroviral drugs against Plasmodium falciparum Antimicrobial Agents and ChemoTherapy 55(11): 5073-5077
Benito, A.; Roche, J.; Molina, R.; Amela, C.; Alvar, J. 1995: In vitro susceptibility of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine, and sulfadoxine/pyrimethamine in Equatorial Guinea American Journal of Tropical Medicine and Hygiene 53(5): 526-531
Mishra, N.C.; Sharma, M.; Sharma, A. 1999: Inhibitory effect of piceatannol, a protein tyrosine kinase inhibitor, on asexual maturation of Plasmodium falciparum Indian Journal of Experimental Biology 37(4): 418-420
Venkataramaiah, T.; Gajanana, A. 1987: Evaluation of Plasmodium falciparum-microsomal in vitro system for testing pro-drugs Indian Journal of Medical Research 86: 579-581
Kaddouri, H.; Djimdé, A.; Dama, S.; Kodio, A.; Tekete, M.; Hubert, V.ér.; Koné, A.; Maiga, H.; Yattara, O.; Fofana, B.; Sidibe, B.; Sangaré, C.P.O.; Doumbo, O.; Le Bras, J. 2008: Baseline in vitro efficacy of ACT component drugs on Plasmodium falciparum clinical isolates from Mali International Journal for Parasitology 38(7): 791-798
Randrianarivelojosia, M.; Randrianasolo, L.; Randremanana, R.V.; Randriamanantena, A.; Ratsimbasoa, Aène.; Rakotoson, J-Désiré. 2004: Susceptibility of Plasmodium falciparum to the drugs used to treat severe malaria (quinine) and to prevent malaria (mefloquine, cycloguanil) in Comoros Union and Madagascar South African Medical Journal 94(1): 47-51
Penali, L.K.; Kone, M.; Komenan, A.; Coulibaly, L. 1993: Decrease in chloroquine resistant Plasmodium falciparum in the Abidjan region (Ivory Coast) Medecine Tropicale: Revue du Corps de Sante Colonial 53(2): 191-194
Charmot, G.; Coulaud, J.P. 1990: Propositions thérapeutiques dans le paludisme A Plasmodium falciparum : le traitement du paludisme : A Plasmodium falciparum en Afrique (à l'exception des formes pernicieuses) - Treatment of malaria at Plasmodium falciparum in Africa (except cerebral malaria) Medecine Tropicale 50(1): 103-108
Utaida, S.; Auparakkitanon, S.; Wilairat, P. 2014: Synergism of antimalarial antibiotics with hydrogen peroxide in inhibiting Plasmodium falciparum growth in culture Southeast Asian Journal of Tropical Medicine and Public Health 45(1): 1-5